| OSTEOTECH, INC. and SUBSIDIARIES | ||||||
| CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||
| (dollars in thousands, except per share data) | ||||||
| (unaudited) | ||||||
| Three Months | Six Months | |||||
| Ending June 30, | Ending June 30, | |||||
| 2010 | 2009 | 2010 | 2009 | |||
| Revenue | $ 23,997 | $ 23,471 | $ 46,524 | $ 47,402 | ||
| Cost of revenue | 11,922 | 11,940 | 23,479 | 23,904 | ||
| Gross profit | 12,075 | 11,531 | 23,045 | 23,498 | ||
| Marketing, selling and | ||||||
| general and administrative expenses | 10,390 | 10,768 | 21,093 | 22,386 | ||
| Research and development expenses | 1,051 | 1,998 | 2,259 | 3,651 | ||
| 11,441 | 12,766 | 23,352 | 26,037 | |||
| Operating income (loss) | 634 | (1,235) | (307) | (2,539) | ||
| Interest expense, net | (316) | (355) | (655) | (709) | ||
| Other | (147) | 131 | (334) | 48 | ||
| Income (loss) before income taxes | 171 | (1,459) | (1,296) | (3,200) | ||
| Income tax provision (benefit) | 56 | (255) | 172 | (200) | ||
| Net income (loss) | $ 115 | $ (1,204) | $ (1,468) | $ (3,000) | ||
| Income (loss) per share: | ||||||
| Basic | $ 0.01 | $ (0.07) | $ (0.08) | $ (0.17) | ||
| Diluted | $ 0.01 | $ (0.07) | $ (0.08) | $ (0.17) | ||
| Shares used in computing earnings (loss) per share: | ||||||
| Basic | 18,069,937 | 18,004,217 | 18,098,827 | 17,882,059 | ||
| Diluted | 18,201,915 | 18,004,217 | 18,098,827 | 17,882,059 | ||
